Leveraging the Power of Multi-Omics Platforms to Inform Biologically Meaningful Target & Biomarker Discovery for More Impactful & Successful Therapeutic Development
1:15 pm - Tuesday 8th December 2026
Analysis of multi-omics data sets represents a powerful tool to understand human biological and functional context for novel target discovery and mechanistic insights for therapeutic development.
Join this workshop to delve into best approaches to access and standardize multiomics datasets and leverage AI/ML platforms to drive biologically meaningful target and biomarker identification to increase the rate of clinical success from discovery.
Workshop Highlights Include:
- How much data is enough? Understanding best approaches to access and combine proprietary and public datasets to train AI/ML computational multi-omics platforms
- Undergoing multi-omics analysis to drive pathway and target discovery, highlighting the significance of biological validation to improve likelihood of success in the clinic
- Understanding applications of AI/ML models to leverage multi-omics data and functional context to identify biomarkers for patient responders and non-responders
